SCHEMBL9819797

SCHEMBL9819797

c1ccc(CCCCCCNCCCCc2ccccc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 11/20 1.00
CHRM2 P08172 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9819849 1.00 SIGMAR1 (1.00) SIGMAR1CHRM2
SCHEMBL8092970 1.00 SIGMAR1 (1.00) SIGMAR1CHRM2
SCHEMBL9655857 1.00 SIGMAR1 (1.00) SIGMAR1CHRM2
SCHEMBL9819742 1.00 SIGMAR1 (1.00) SIGMAR1CHRM2
SCHEMBL9819830 1.00 SIGMAR1 (1.00) SIGMAR1CHRM2
SCHEMBL8084446 0.98 SIGMAR1 (1.00) SIGMAR1
SCHEMBL8092723 0.98 SIGMAR1 (1.00) SIGMAR1
SCHEMBL8084220 0.98 SIGMAR1 (0.95) SIGMAR1
SCHEMBL8091327 0.96 SIGMAR1 (1.00) SIGMAR1
SCHEMBL7369457 0.96 SIGMAR1 (1.00) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4987132-A PLATELET ACTIVATING FACTOR ANTAGONISTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1991-01-22 US disclosed
EP-0279681-A2 Saturated heterocyclic carboxamide derivatives YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1988-08-24 EP disclosed